Detection of urinary cystatin-c in IUGR neonates by immunoblot SDS-PAGE

Chiara Grasselli1

  • 1Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy.

Pediatrics and Neonatology
|September 14, 2022
PubMed

Insights

Monomeric Cystatin-C (cyst-C) is present in the urine of neonates with intrauterine growth retardation (IUGR), indicating potential kidney injury. This finding suggests monomeric cyst-C as an early marker for monitoring renal health in IUGR infants.

Area of Science:

  • Nephrology
  • Biochemistry

Background:

  • Intrauterine growth retardation (IUGR) is a known risk factor for impaired kidney development and function.
  • Cystatin-C (cyst-C) is a molecule that can indicate both glomerular and proximal renal injury.
  • Previous studies detected elevated urinary cyst-C levels in neonates with IUGR.

Purpose of the Study:

  • To investigate the specific forms (monomer/polymer) of Cystatin-C (cyst-C) in the urine of neonates with intrauterine growth retardation (IUGR).
  • To determine if the presence or absence of specific cyst-C conformations provides additional information on renal function in IUGR neonates.

Main Methods:

  • Urinary samples were collected from 64 neonates with IUGR and 86 healthy appropriate for gestational age (AGA) controls.
  • Immunoblot SDS-PAGE was used to analyze the forms of urinary cyst-C.

Main Results:

  • SDS-PAGE revealed a reactive complex of approximately 70 kDa in all urine samples.
  • The monomeric form of cyst-C (13 kDa) was detected in 78% of IUGR neonates, compared to 12% of AGA neonates.

Conclusions:

  • The presence of monomeric cyst-C in IUGR neonates suggests impaired tubular reabsorption.
  • Monomeric cyst-C shows potential as an early biochemical marker for identifying IUGR neonates at risk of renal injury.
  • Monitoring IUGR infants for monomeric cyst-C can aid in early detection and management of potential renal complications.
Abstract

Related Concept Videos